StockData
ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc. (CLPT) stock

CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3021% above fair value
$8.48−0.01 (-0.12%)

Close on Nov 13, 2026Market cap $271.82MP/E –Yield –

ClearPoint Neuro total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

ClearPoint Neuro's total debt was $50.84M at Sep 30, 2026. For fiscal 2025 it was $49.08M. The highest annual figure on record is $49.08M in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$49.08M–
FY2024Dec 31, 2024$0-100.0%
FY2014Dec 31, 2014$4.02M+4.3%
FY2013Dec 31, 2013$3.85M+92.6%
FY2012Dec 31, 2012$2.00M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$50.84M+74.1%
Q2 FY2026Jun 30, 2026$50.23M+74.1%
Q1 FY2026Mar 31, 2026$49.64M–
Q4 FY2025Dec 31, 2025$49.08M+5870.3%
Q3 FY2025Sep 30, 2025$29.20M+4772.7%
Q2 FY2025Jun 30, 2025$28.85M–
Q4 FY2024Dec 31, 2024$0–
Q3 FY2020Sep 30, 2020$822.02K–
Q2 FY2020Jun 30, 2020$599.32K–

More ClearPoint Neuro figures

See a number that looks wrong?